Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 13/1/2021
SIETES contiene 93213 citas

 1 a 20 de 276 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Dommasch ED, Kim SC, Lee MP, Gagne JJ. Risk of serious infection in patients receiving systemic medications for the treatment of psoriasis. JAMA Dermatol 2019:10 de mayo. [Ref.ID 103131]
2. Cita con resumen
N.L.. Why gene-therapy drugs are so expensive. The Economist 2016:1. [Ref.ID 100562]
5. Cita con resumen
Ellis SG, Kereiakes DJ, Metger C, Caputo RP, Rizik DG, Teirstein PS, Litt MR, Kini A, Kabour A, Marx SO, Popma JJ, McGreevy R, Zhang ZS, Simonton C, Stone GW, for the ABSORB III Investigators. Everolimus-eluting bioresorbable scaffolds for coronary artery disease. N Engl J Med 2015;373:1905-15. [Ref.ID 99671]
6. Cita con resumen
Boeckh M, Nichols WG, Chemaly RF, Papanicolaou GA, Wingard JR, Xie H, Syrjala KL, Flowers MED, Stevens-Ayers T, Jerome KR, Leisenring W. Valganciclovir for the prevention of complications of late cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a randomized trial. Ann Intern Med 2015;162:1-10. [Ref.ID 98728]
7. Cita con resumen
Anónimo. Vaccines for travelers. Med Lett Drugs Ther 2014;56:115-20. [Ref.ID 98403]
8. Cita con resumen
Anónimo. AINS: phlegmons, cellulites cervicales?. Prescrire 2014;34:516. [Ref.ID 98077]
9. Cita con resumen
Chemaly RF, Ullmann AJ, Stoelben S, Richard MP, Bornháuser M, Groth C, Einsele H, Silverman M, Mullane KM, Brown J, Nowak H, Kölling K, Stobernack HP, Lischka P, Zimmermann H, Rübsamen-Schaeff H, Champlin RE, Ehninger G, for the AIC246 Study. Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation. N Engl J Med 2014;370:1781-9. [Ref.ID 97588]
10. Cita con resumen
Anónimo. Aflibercept (Zaltrap). Prescrire 2014;34:258. [Ref.ID 97436]
11.Tiene citas relacionadas
Thomas DL. A case for ribavirin to treat chronic hepatitis E. N Engl J Med 2014;370:1162-3. [Ref.ID 97312]
12.Tiene citas relacionadas Cita con resumen
Kamar N, Izopet J, Tripon S, Bismuth M, Hillaire S, Dumortier J, Radenne S, Coilly A, Garrigue V, D'Alteroche L, Buchler M, Couzi L, Lebray P, Dharancy S, Minello A, Hourmant M, Roque-Afonso AM, Abravanel F, Pol S, Rostaing L, Mallet V. Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med 2014;370:1111-20. [Ref.ID 97310]
13. Cita con resumen
Winthrop KL, Baddley JW, Chen L, Liu L, Grijalva CG, Delzell E, Beukelman T, Patkar NM, Xie F, Saag KG, Herrinton LJ, Solomon DH, Lewis JD, Curtis JR. Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster. JAMA 2013;309:887-95. [Ref.ID 95064]
14.Tiene citas relacionadas
Coles AJ, Twyman CL, Arnold DL, Cohen JA, Confavreux C, Fox EJ, Hartung H-P, Havrdova E, Selmaj KW, Weiner HL, Miller T, Fisher E, Sandbrink R, Lake SL, Margolin DH, Oyuela P, Panzara MA, Compston DAS, for the CARE-MS II Investigators. Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial. Lancet 2012;380:1829-39. [Ref.ID 94117]
15.Tiene citas relacionadas
Cohen JA, Coles AJ, Arnold DL, Confavreux C, Fox EJ, Hartung H-P, Havrdova E, Selmaj KW, Weiner HL, Fisher E, Brinar VV, Giovannoni G, Stojanovic M, Ertik BI, Lake SL, Margolin DH, Panzara MA, Compston DAS, for the CARE-MS I investigators. Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial. Lancet 2012;380:1818-29. [Ref.ID 94116]
16.Tiene citas relacionadas
Sprenger T, Kappos L. Alemtuzumab for multiple sclerosis: who and when to treat?. Lancet 2012;380:1795-7. [Ref.ID 94115]
17.Tiene citas relacionadas Cita con resumen
Anónimo. Alemtuzumab for multiple sclerosis. Lancet 2012;380:1792. [Ref.ID 94114]
18. Cita con resumen
Anónimo. Pneumococcal vaccine for adults. Med Lett Drugs Ther 2012;54:87-8. [Ref.ID 93956]
19. Cita con resumen
Zhang J, Xie F, Delzell E, Chen L, Winthrop KL, Lewis JD, Saag KG, Baddley JW, Curtis JR. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. JAMA 2012;308:43-9. [Ref.ID 93391]
Seleccionar todas
 1 a 20 de 276 siguiente >>